Literature DB >> 31433209

Inhibition of Mycobacterium tuberculosis tRNA-Ligases Using siRNA-Based Gene Silencing Method: A Computational Approach.

Partha Sarathi Mohanty1, Sandeep Sharma1, Farah Naaz1, Dilip Kumar1, Archana Raikwar1, Shripad A Patil2.   

Abstract

Tuberculosis (TB) is a major public health problem in several countries. Development of first-line and second-line drug resistance strains of Mycobacterium tuberculosis further complicated the management of the disease. Despite available drugs to treat TB, 1.6 million people died from the disease in 2017. In this study, we designed 10 siRNAs against 8 tRNA ligases of M. tuberculosis and validated their usefulness for inhibition of protein synthesis by using computational approach. We found that the predicted siRNAs efficiently form seed duplex complex against their respective mRNA targets. Other different computational approaches were also undertaken to assess the stability, accessibility, and strength of seed duplex complex of designed siRNA and targeted mRNA. On the basis of the computational approach, we reciprocated that the technique will help in opening a new window in the field of TB control program and could be taken for further clinical studies to find their appropriateness for TB eradication.

Entities:  

Keywords:  Mycobacterium tuberculosis; aminoacyl–tRNA synthetase; gene silencing; siRNA; tRNA ligases; tuberculosis

Mesh:

Substances:

Year:  2019        PMID: 31433209     DOI: 10.1089/cmb.2019.0156

Source DB:  PubMed          Journal:  J Comput Biol        ISSN: 1066-5277            Impact factor:   1.479


  1 in total

1.  A Comprehensive Computational Investigation into the Conserved Virulent Proteins of Shigella species Unveils Potential Small-Interfering RNA Candidates as a New Therapeutic Strategy against Shigellosis.

Authors:  Parag Palit; Farhana Tasnim Chowdhury; Namrata Baruah; Bonoshree Sarkar; Sadia Noor Mou; Mehnaz Kamal; Towfida Jahan Siddiqua; Zannatun Noor; Tahmeed Ahmed
Journal:  Molecules       Date:  2022-03-17       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.